HIV physically damages the body by destroying immune cells called CD4 cells, which coordinate your defense against infections. A single infected CD4 cell can produce roughly 10,000 new viral copies, and as the virus spreads, the progressive loss of these cells leaves the body increasingly vulnerable to infections, cancers, and organ damage that a healthy immune system would normally prevent. The physical effects range from flu-like symptoms in the earliest weeks to serious complications affecting the skin, brain, heart, gut, and metabolism over months and years if the virus isn’t controlled.
How HIV Attacks Immune Cells
HIV targets CD4 cells specifically because these cells carry surface receptors the virus can latch onto. The virus binds to the outside of a CD4 cell, fuses with its membrane, and slips inside. Once there, it hijacks the cell’s machinery to make copies of itself. Each infected cell churns out thousands of new viral particles before dying, and those particles go on to infect more CD4 cells in a destructive cycle that accelerates over time.
The damage is especially severe in the gut, which contains over 85% of the body’s lymphoid tissue and more than 90% of all lymphocytes. The gut is packed with the exact type of CD4 cells HIV prefers: activated memory cells that express the co-receptors HIV uses to enter. Within weeks of infection, HIV strips this tissue of its CD4 cells far more aggressively than it depletes them in the bloodstream. That early gut damage sets the stage for many of the physical problems that follow.
Early Physical Symptoms
The first physical signs of HIV typically appear within two to four weeks of infection, during what’s called the acute stage. Many people experience flu-like symptoms: fever, headache, and rash. These symptoms reflect the immune system’s initial battle against the virus and usually resolve on their own within a few weeks. Some people have no noticeable symptoms at all during this phase, which is one reason the virus often goes undetected early on.
Gut Damage and Nutrient Absorption
HIV doesn’t just deplete immune cells in the gut. It physically reshapes the intestinal lining. The finger-like projections called villi, which absorb nutrients from food, shrink and flatten. At the same time, the deeper tissue layers develop scarring from collagen buildup, disrupting the architecture the gut needs to function normally. The result is reduced nutrient absorption even in people who are eating enough, contributing to diarrhea, weakness, and weight loss.
This intestinal damage also breaks down the gut’s physical barrier. Normally, tight junctions between cells in the intestinal wall keep bacteria and their byproducts contained. HIV loosens those junctions, allowing bacterial toxins to leak into the bloodstream, a process called microbial translocation. This leakage triggers persistent, body-wide inflammation that drives disease progression and damages organs far from the gut itself. Notably, this low-grade inflammatory leak continues even in people on effective treatment, though at lower levels.
Skin Conditions
Skin problems are among the most visible physical effects of HIV and often worsen as CD4 counts drop. Seborrheic dermatitis, which causes flaky, red, scaly patches on the face and scalp, affects 34% to 83% of people with HIV and tends to become more severe as the immune system weakens. Shingles, caused by reactivation of the chickenpox virus, appears as painful clusters of blisters along a strip of skin and is most common when CD4 counts fall below 200.
At very low CD4 counts (below 100), skin conditions become more serious and harder to treat. Herpes simplex can cause chronic, deep ulcers that don’t heal. Molluscum contagiosum, which produces small wart-like bumps, can spread across the face and body in disfiguring numbers. Kaposi sarcoma, a cancer that appears as brown, pink, red, or purple raised lesions on the skin, is directly linked to advanced HIV and is considered an AIDS-defining condition. People with HIV also develop bacterial skin infections like MRSA abscesses at 6 to 18 times the rate of people without HIV.
Wasting and Metabolic Changes
HIV wasting syndrome is defined as involuntary loss of more than 10% of body weight, combined with diarrhea, weakness, or fever lasting at least 30 days. Before effective treatment existed, this was one of the most recognizable physical signs of advanced HIV, sometimes called “slim disease.” The weight loss comes from a combination of poor nutrient absorption, chronic diarrhea, and the body’s inability to properly use the nutrients it does absorb. Lean muscle mass drops, leaving people visibly thin and physically weak.
Treatment itself can cause a different set of body changes. Some antiretroviral medications lead to fat redistribution: fat accumulates around the abdomen and upper back (sometimes forming a visible pad at the base of the neck), while fat in the face, buttocks, and limbs thins out. With current drug regimens, these changes occur in fewer than 5% of people. A more common issue today is gradual weight gain after starting treatment, which appears to be more pronounced with certain newer drug classes. This weight gain, combined with HIV-related inflammation, contributes to longer-term metabolic risks.
Heart and Blood Vessel Damage
People with HIV face roughly twice the risk of developing cardiovascular disease compared to people without HIV, even after accounting for traditional risk factors like smoking, high cholesterol, and high blood pressure. The primary driver is chronic inflammation. HIV keeps the immune system in a state of sustained activation, and the inflammatory molecules it produces damage blood vessel walls over time, accelerating the buildup of arterial plaque.
This elevated inflammation decreases with treatment but never fully returns to normal. People with well-controlled HIV still show higher levels of cardiovascular inflammation than the general population. The combination of HIV-specific inflammation, higher rates of traditional risk factors in people living with HIV, and some metabolic effects of long-term medication creates a compounding cardiovascular burden that becomes increasingly relevant as people with HIV live longer on effective treatment.
Neurological and Motor Effects
HIV can cross into the brain and nervous system, causing a range of physical neurological problems collectively known as HIV-associated neurocognitive disorders. Early motor symptoms include clumsiness, poor balance, and general weakness. As the condition progresses, people may develop difficulty walking, slowed movements, exaggerated reflexes, and problems with coordination and fine motor tasks like writing or buttoning a shirt.
Peripheral neuropathy, damage to the nerves in the hands and feet, is another common physical effect. It causes numbness, tingling, burning pain, and in severe cases, enough sensory loss to affect everyday activities like driving. In the most advanced stages of HIV-related brain disease, people can develop severe cognitive and motor decline, including an inability to walk or speak. In children born with HIV, the virus can slow or reverse the development of motor milestones and fine motor skills.
How Treatment Changes the Physical Picture
Modern antiretroviral therapy dramatically alters the physical trajectory of HIV. By suppressing viral replication, treatment allows CD4 cell counts to recover, which prevents or reverses many of the immune-related complications described above. Skin conditions clear or become manageable. The risk of wasting drops sharply. Opportunistic infections become rare. Continuous treatment also significantly reduces non-AIDS events like cardiovascular disease compared to intermittent or no treatment, largely by keeping inflammation lower.
Still, treatment doesn’t erase all physical effects. Gut barrier damage and microbial translocation persist at reduced levels. Cardiovascular inflammation remains above normal. Some degree of immune activation continues indefinitely. And the medications themselves carry physical side effects, from weight gain to, less commonly, changes in fat distribution. The physical reality of living with HIV on effective treatment is far removed from untreated disease, but it involves managing a chronic condition where inflammation and its downstream effects remain ongoing concerns.